You have read all your free articles, to continue reading subscribe to read the rest of this content.
AstraZeneca's EVP of Oncology R&D, José Baselga, shares his top five takeaways from the AACR COVID-19 and Cancer virtual meeting. The American Association for Cancer Research (AACR) organized a COVID-19 and Cancer virtual meeting, bringing together voices from across the healthcare continuumAlready a subscriber Login You have read all your…
Isofol Medical has announced that neither the primary endpoint of Overall Response Rate (ORR) nor the key secondary endpoint in Progression Free Survival (PFS) achieved statistical significance in the multi-center, international Phase III AGENT Study of arfolitixorin in combination with 5-FU, oxalipAlready a subscriber Login You have read all your…
Medivir announces that Idenix Pharmaceuticals today released interim data from the ongoing phase II HELIX-1 clinical trial evaluating an all-oral, direct-acting antiviral (DAA) HCV combination regimen of samatasvir (IDX719), Idenix’s once-daily pan-genotypic NS5A inhibitor, and simeprevir , a oncAlready a subscriber Login You have read all your free articles, to continue…
Norwegian company Vaccibody is moving forward with the first vaccination of a patient with the human papillomavirus, HPV-virus, in a phase IIa study using the company´s immunotherapy platform. The primary objectives of the phase IIa study are to assess T cell mediated immune responses in the perAlready a subscriber Login…
